We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+5.28%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$17.8B
AUM Growth
+$1.26B
Cap. Flow
+$567M
Cap. Flow %
3.2%
Top 10 Hldgs %
11.28%
Holding
2,904
New
221
Increased
694
Reduced
820
Closed
148

Top Sells

Rank Stock Value
1
SBUX icon
Starbucks
SBUX
+$64.8M
2
HRL icon
Hormel Foods
HRL
+$61.4M
3
GILD icon
Gilead Sciences
GILD
+$59.9M
4
HLT icon
Hilton Worldwide
HLT
+$54.7M
5
FTI icon
TechnipFMC
FTI
+$51M

Sector Composition

Rank Sector Weight
1 Technology 14.87%
2 Healthcare 14.18%
3 Financials 11.71%
4 Industrials 10.79%
5 Consumer Discretionary 10.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALKS icon
1076
Alkermes
ALKS
$8.79B
$189K ﹤0.01%
4,035
+735
+22% +$35K
ZTS icon
1077
Zoetis
ZTS
$32.2B
$189K ﹤0.01%
3,641
+691
+23% +$35K
ISRA icon
1078
VanEck Israel ETF
ISRA
$152M
$188K ﹤0.01%
6,766
BNS icon
1079
Scotiabank
BNS
$106B
$187K ﹤0.01%
3,553
TXT icon
1080
Textron
TXT
$16.7B
$186K ﹤0.01%
4,711
-8,519
-64% -$335K
TSCO icon
1081
Tractor Supply
TSCO
$16.7B
$185K ﹤0.01%
13,810
-2,000
-13% -$33.3K
WSFS icon
1082
WSFS Financial
WSFS
$4.14B
$185K ﹤0.01%
5,118
TLP
1083
DELISTED
Transmontaigne
TLP
$185K ﹤0.01%
4,500
+2,970
+194% +$124K
ENR icon
1084
Energizer
ENR
$1.44B
$183K ﹤0.01%
3,697
-100
-3% -$4.91K
WFC.PRV
1085
DELISTED
Wells Fargo & Company Depositary Shares, each representing a 1/1,000th interest in a share of Non-Cu
WFC.PRV
$183K ﹤0.01%
6,868
-539
-7% -$14.8K
MLM icon
1086
Martin Marietta Materials
MLM
$34.3B
$181K ﹤0.01%
1,013
-1,800
-64% -$344K
DSGX icon
1087
Descartes Systems
DSGX
$6.09B
$180K ﹤0.01%
8,400
RSPT icon
1088
Invesco S&P 500 Equal Weight Technology ETF
RSPT
$5.43B
$179K ﹤0.01%
17,000
AAON icon
1089
Aaon
AAON
$8.27B
$178K ﹤0.01%
9,357
+150
+2% +$2.76K
HLT icon
1090
Hilton Worldwide
HLT
$75.3B
$178K ﹤0.01%
2,597
-775,523
-100% -$54.7M
RWR icon
1091
State Street SPDR Dow Jones REIT ETF
RWR
$1.91B
$178K ﹤0.01%
1,830
-177
-9% -$17.8K
FDS icon
1092
Factset
FDS
$9.46B
$177K ﹤0.01%
1,100
-42
-4% -$7.24K
RCL icon
1093
Royal Caribbean
RCL
$81.8B
$177K ﹤0.01%
2,375
-1,925
-45% -$136K
INDY icon
1094
iShares S&P India Nifty 50 Index Fund
INDY
$554M
$176K ﹤0.01%
5,924
RHI icon
1095
Robert Half
RHI
$4.07B
$176K ﹤0.01%
4,677
-428,648
-99% -$16.3M
VIAB
1096
DELISTED
Viacom Inc. Class B
VIAB
$176K ﹤0.01%
4,643
-947
-17% -$39.2K
IEFA icon
1097
iShares Core MSCI EAFE ETF
IEFA
$188B
$175K ﹤0.01%
3,175
PNY
1098
DELISTED
PIEDMONT NATURAL GAS CO INC(NC
PNY
$175K ﹤0.01%
2,922
+300
+11% +$18K
ALB icon
1099
Albemarle
ALB
$13.7B
$174K ﹤0.01%
2,046
+94
+5% +$7.74K
IPAR icon
1100
Interparfums
IPAR
$3.99B
$174K ﹤0.01%
5,410

Similar funds

Glenmede Trust's Q3 2016 Portfolio in Review

As of Q3 2016, Glenmede Trust held 2,904 positions worth $17.8B, up 7.6% from $16.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Glenmede Trust deployed $567M of net new capital in Q3 2016, opening 221 new positions and adding to 694 existing holdings. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 2,050,199 shares worth $37.2M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Starbucks, an estimated $64.8M trimmed.

  • Glenmede Trust's largest Q3 2016 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 2,050,199 shares worth $37.2M.
  • Glenmede Trust added most to McKesson in Q3 2016, an estimated $82.7M increase.
  • Glenmede Trust's biggest Q3 2016 reduction was Starbucks, cutting an estimated $64.8M.
  • Glenmede Trust fully exited WILSHIRE BANCORP INC in Q3 2016, selling an estimated $18.5M.
  • Glenmede Trust's ten largest holdings make up 11% of its $17.8B portfolio in Q3 2016.
  • Glenmede Trust opened 221 new positions and closed 148 in Q3 2016.
  • Glenmede Trust's portfolio value rose 7.6% quarter-over-quarter to $17.8B.

Based on Glenmede Trust's 13F filing for Q3 2016, filed 14 Nov 2016.